Literature DB >> 2856251

Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.

J Yokota1, T Akiyama, Y K Fung, W F Benedict, Y Namba, M Hanaoka, M Wada, T Terasaki, Y Shimosato, T Sugimura.   

Abstract

Nine lung small-cell carcinoma (SCC) cell lines and 9 lung non-SCC cell lines were examined for structural changes of the retinoblastoma (RB) gene as well as its expression using a complementary DNA probe. The RB protein product was investigated using an anti-RB antibody which we produced. Although homozygosity or hemizygosity of the RB gene was suggested in 8 of 9 SCCs and one of 2 large cell carcinomas (LCCs) by Southern blot analysis using an RB cDNA probe and polymorphic DNA markers for chromosome 13, no obvious structural changes of the RB gene were detected in these 18 cell lines. However, RB transcripts were either markedly reduced in quantity or abnormal in length in 3 of 9 SCCs. The specific 115 kD protein was not immunoprecipitated by the anti-RB antibody in all 9 SCCs with either normal or abnormal size RB mRNA. Three of 4 adenocarcinomas (AdCs), all 3 squamous cell carcinomas, and one of 2 LCCs expressed normal size RB mRNA, and the 115 kD protein was immunoprecipitated by the anti-RB antibody. The 115 kD protein was also absent in one of 2 LCCs with shortened RB mRNA and in one of 4 AdCs with low level of RB mRNA expression. These results strongly suggest that inactivation of the RB gene might be involved in the development of lung cancers, especially of SCCs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2856251

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  58 in total

1.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Phosphorylation of the retinoblastoma protein by cdk2.

Authors:  T Akiyama; T Ohuchi; S Sumida; K Matsumoto; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  The retinoblastoma gene product regulates Sp1-mediated transcription.

Authors:  S J Kim; U S Onwuta; Y I Lee; R Li; M R Botchan; P D Robbins
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

5.  Adenovirus E1A is associated with a serine/threonine protein kinase.

Authors:  C H Herrmann; L K Su; E Harlow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering.

Authors:  D J Templeton; S H Park; L Lanier; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 7.  Role of the retinoblastoma gene in the initiation and progression of human cancer.

Authors:  W F Benedict; H J Xu; S X Hu; R Takahashi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

8.  Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product.

Authors:  W G Kaelin; M E Ewen; D M Livingston
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  Perturbation of the p53 response by human papillomavirus type 16 E7.

Authors:  E S Hickman; S Bates; K H Vousden
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  The retinoblastoma protein physically associates with the human cdc2 kinase.

Authors:  Q J Hu; J A Lees; K J Buchkovich; E Harlow
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.